Effects of therapeutically approved individual bile acids on the development of metabolic dysfunction-associated steatohepatitis a low bile acid mouse model

Rulaiha Taylor(Rutgers, The State University of New Jersey), Grace L. Guo(Rutgers, The State University of New Jersey), Zhenning Yang(Rutgers, The State University of New Jersey), Ill Yang(Rutgers, The State University of New Jersey), Katherine Otersen(Rutgers, The State University of New Jersey), Anita Brinker(Rutgers, The State University of New Jersey), Bo Kong(Rutgers, The State University of New Jersey), Zakiyah Henry(Rutgers, The State University of New Jersey), Brian Buckley(Rutgers, The State University of New Jersey), Vik Meadows(Rutgers, The State University of New Jersey), Veronia Basaly(Rutgers, The State University of New Jersey), Anisha Bhattacharya(Rutgers, The State University of New Jersey), Gina E Capece(Rutgers, The State University of New Jersey), Laurie B. Joseph(Rutgers, The State University of New Jersey), Peihong Zhou(Rutgers, The State University of New Jersey), Lauren M. Aleksunes(Rutgers, The State University of New Jersey), Stephanie Mera(Rutgers, The State University of New Jersey), Troy A. Roepke(Rutgers, The State University of New Jersey)
Toxicological Sciences
September 18, 2024
Cited by 6


Related Papers